Our Science

Publications Vaxwave®

Bernstein, D. I. (2017). Congenital cytomegalovirus: a “now” problem—no really, now. Clinical and Vaccine Immunology, 24(1), e00491-16. PubMed

MacMaster, P. P., Shields, J. L., Alayo, Q. A., Cabral, C., Jimenez, J., Mondesir, J., ... & Provine, N. M. (2017). Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens. Vaccine, 35(1), 1-9. PubMed

Schleiss, M. R., Berka, U., Watson, E., Aistleithner, M., Kiefmann, B., Mangeat, B., ... & Zabeli, J. C. (2017). Additive protection against congenital cytomegalovirus conferred by combined glycoprotein B/pp65 vaccination using a lymphocytic choriomeningitis virus vector. Clinical and Vaccine Immunology, 24(1), e00300-16. PubMed

Wingerath, J., Ostroumov, D., Woller, N., Manns, M. P., Pinschewer, D. D., Orlinger, K., ... & Wirth, T. C. (2017). Recombinant LCMV Vectors Induce Protective Immunity following Homologous and Heterologous Vaccinations. Molecular Therapy, 25(11), 2533-2545. PubMed

Cardin, R. D., Bravo, F. J., Pullum, D. A., Orlinger, K., Watson, E. M., Aspoeck, A., ... & Bernstein, D. I. (2016). Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection. Vaccine, 34(17), 1993-1999. PubMed

Flatz, L., Cheng, C., Wang, L., Foulds, K., Ko, S. Y., Kong, W. P., ... & Asmal, M. (2012). Gene-based vaccination with a mis-matched envelope protects against simian immunodeficiency virus infection in non-human primates. Journal of virology, JVI-00599. PubMed

Flatz, L., Hegazy, A. N., Bergthaler, A., Verschoor, A., Claus, C., Fernandez, M., ... & Van Den Broek, M. (2010). Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nature medicine, 16(3), 339. PubMed

Publications TheraT®

Page, N., Klimek, B., De Roo, M., Steinbach, K., Soldati, H., Lemeille, S., ... & Lingner, T. (2018). Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8+ T Cells. Immunity, 48(5), 937-950. PubMed

Kallert, S. M., Darbre, S., Bonilla, W. V., Kreutzfeldt, M., Page, N., Müller, P., ... & Löhning, M. (2017). Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy. Nature communications, 8, 15327. PubMed